Helicobacter pylori patients.
Conditions
Interventions
Intervention 1: Intervention group: receiving a 14-day regimen of Helicobacter plus statin. Intervention 2: Intervention group: receiving a 14-day regimen of Helicobacter plus n a cystein. Interventio
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Informed written consent Helicobacter pylori positive patients with definitive diagnosis by stool HP antigen test referring to Ghaem Hospital Age category 18 years and above
Exclusion criteria
Exclusion criteria: Canceling the continuation of the plan pregnancy breastfeeding Weight loss of more than 5% over the past six months Dysphagia and positive personal or family history of gastrointestinal malignancy Receiving statin and NAC during the last 6 months Having a history of gastric surgery Receiving PPI and antibiotics in the past month The presence of known drug sensitivity to any of the drugs used Known liver problems The presence of obvious gastrointestinal bleeding Occurrence of possible drug side effects due to drug intervention and possible myopathy due to statin use
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Helicobacter pylori infection recovery rate. Timepoint: Before starting treatment and one month after starting treatment. Method of measurement: Based on Helicobacter pylori antigen test in stool exam. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactjavad aishy
Mashhad University of Medical Sciences
Outcome results
None listed